Effects of arginine-vasopressin (AVP) on long-term potentiation in intact anesthetized rats

被引:21
作者
Dubrovsky, B
Tatarinov, A
Gijsbers, K
Harris, J
Tsiodras, A
机构
[1] McGill Univ, Ctr Hlth, Montreal, PQ H3G 1X9, Canada
[2] Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland
关键词
arginine; vasopressin; LTP; in vivo; in vitro;
D O I
10.1016/S0361-9230(02)00961-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We studied the effects of the neuropeptide arginine-vasopressin (AVP) on the long-term potentiation (LTP) paradigm in the dentate gyrus (DG) of urethane intact anesthetized rats. Intracerebroventricular injection of 1 mug of the hormone in 1 mul of physiological solution 3 min before tetanization, produced a significant increase in both components of the perforant path-evoked potentials (EP) in the DG. The effects were already evident 1 min after tetanization. Amplitude of the EPs increased continuously for the 2 h of recording time, reaching values 100% above baseline, reference levels. In contrast, in previous in vitro studies [11], enhancement of LTP with AVP appeared only after 15 min of exposure of the hippocampal slice to the hormone, increased EPSPs were no higher than 50% from baseline, reached a plateau at 40 min decreasing slowly thereafter. Not only quantitative but also qualitative differences can be observed between in vitro and in vivo intact preparations in response to identical hormones. This study emphasizes the importance of hormone neurotransmitter interactions in determining electrophysiological characteristics of response to AVP. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:467 / 472
页数:6
相关论文
共 56 条
[1]   Neuromodulation of memory in the hippocampus by vasopressin [J].
Alescio-Lautier, B ;
Paban, V ;
Soumireu-Mourat, B .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 405 (1-3) :63-72
[2]   NONSYNAPTIC DIFFUSION NEUROTRANSMISSION (NDN) IN THE BRAIN [J].
BACHYRITA, P .
NEUROCHEMISTRY INTERNATIONAL, 1993, 23 (04) :297-318
[3]   LONG-LASTING POTENTIATION OF SYNAPTIC TRANSMISSION IN DENTATE AREA OF ANESTHETIZED RABBIT FOLLOWING STIMULATION OF PERFORANT PATH [J].
BLISS, TVP ;
LOMO, T .
JOURNAL OF PHYSIOLOGY-LONDON, 1973, 232 (02) :331-356
[4]  
BOHUS B, 1993, ANN NY ACAD SCI, V689, P285
[5]   VASOPRESSIN (DDAVP) THERAPY IN CHRONIC-SCHIZOPHRENIA - EFFECTS ON NEGATIVE SYMPTOMS AND MEMORY [J].
BRAMBILLA, F ;
BONDIOLOTTI, GP ;
MAGGIONI, M ;
SCIASCIA, A ;
GRILLO, W ;
SANNA, F ;
LATINA, A ;
PICOTTI, GB .
NEUROPSYCHOBIOLOGY, 1988, 20 (03) :113-119
[6]   Spatial, cellular and temporal basis of vasopressin potentiation of norepinephrine-induced cAMP formation [J].
Brinton, RD ;
Thompson, RH ;
Brownson, EA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 405 (1-3) :73-88
[7]  
BRINTON RE, 1989, J NEUROSCI, V9, P752
[8]   VASOPRESSIN AND OXYTOCIN - THEIR ROLE IN NEUROTRANSMISSION [J].
BUIJS, RM .
PHARMACOLOGY & THERAPEUTICS, 1983, 22 (01) :127-141
[9]   VASOPRESSIN CELLS IN THE MEDIAL AMYGDALA OF THE RAT PROJECT TO THE LATERAL SEPTUM AND VENTRAL HIPPOCAMPUS [J].
CAFFE, AR ;
VANLEEUWEN, FW ;
LUITEN, PGM .
JOURNAL OF COMPARATIVE NEUROLOGY, 1987, 261 (02) :237-252
[10]  
Carter C. S., 1997, ANN NY ACAD SCI, V807